Results 31 to 40 of about 486,806 (280)

Cystic fibrosis

The Lancet, 1998
OBJECTIVE: Due to the great advances recently achieved in the treatment of Cystic Fibrosis as well as to the fact that pediatricians need to have a better understanding of this disease, the authors propose an extensive review of the subject. METHODS: We selected the most outstanding publications on Cystic Fibrosis in the international literature of the
B J, Rosenstein, P L, Zeitlin
openaire   +4 more sources

Elevated sweat chloride test: is it always cystic fibrosis?

Italian Journal of Pediatrics, 2021
Background The sweat chloride test (ST) is the gold standard for cystic fibrosis (CF) diagnosis in symptomatic patients, within the newborn screening and in the follow-up of CF patients during molecular therapies.
C. Cimbalo, A. Tosco, V. Terlizzi, A. Sepe, A. Castaldo, L. Salvadori, V. Raia   +6 more
doaj   +1 more source

Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis [PDF]

, 2023
Cystic fibrosis; Guidelines; Variant-specific therapyFibrosis quística; Pautas; Terapia variante específicaFibrosi quística; Pautes; Teràpia variant específicaCystic fibrosis (CF) has entered the era of variant-specific therapy, tailored to the genetic ...
Southern, Kevin, VanDevanter, Donald, Smyth, Alan, Castellani, Carlo, van Koningsbruggen, Silke, Gartner Tizzano, Silvia, Lammertyn, Elise   +6 more
core   +1 more source

The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre [PDF]

, 2008
Background: This study reviews the impact of changing infection control practices at the Manchester Adult Cystic Fibrosis Centre (MACFC) upon the epidemiology of Burkholderia species infections.Methods: We reviewed strain and genomovar typing of all ...
Doherty, Catherine J., Govan, John R., Dodd, Mary E., Webb, A. K., Jones, Andrew M., France, Megan W.   +5 more
core   +1 more source

An exploratory study investigating factors associated with adherence to chest physiotherapy and exercise in adults with cystic fibrosis [PDF]

, 2009
Copyright @ 2009 European Cystic Fibrosis Society. This article is available through Elsevier's Open Access Archives and covered by Elsevier's user license: http://www.elsevier.com/about/open-access/open-access-policies/oa-license-policy/elsevier-user ...
Lynn B. Myers, Myers, LB
core   +1 more source

A metagenomic approach to characterize temperate bacteriophage populations from Cystic Fibrosis and non-Cystic Fibrosis bronchiectasis patients [PDF]

, 2015
Pseudomonas aeruginosa (Pa), normally a soil commensal, is an important opportunistic pathogen in Cystic Fibrosis (CF) and non-Cystic Fibrosis Bronchiectasis (nCFBR).
Bourke, Stephen, Smith, Darren L., Anthony eDe Soyza, Cowley, Lauren A., Perry, J. D. (John), Holt, Giles S., Francesca Louise Claire Everest, Stephen eBourke, Darren L. Smith, Tariq, M. A. (Mohammad), Smith, Darren, Stephen eCummings, Holt, Giles, Clare V. Lanyon, Cowley, Lauren, Jeremy J Barr, Bourke, Stephen J., Barr, Jeremy J., Mohammad Adnan Tariq, Bridge, Simon H., Cummings, Stephen, Perry, John, Audrey Perry, Jeremy J. Barr, Barr, Jeremy, Francesca L. C. Everest, Stephen J. Bourke, Bridge, Simon, Simon H. Bridge, Audrey ePerry, Anthony De Soyza, Simon Harwood Bridge, Stephen P. Cummings, John D. Perry, Tariq, Mohammad, Darren Lee Smith, Everest, Francesca, John D Perry, Giles Samuel Holt, Lauren A. Cowley, Lanyon, Clare, Mohammad A. Tariq, Everest, F. L. C. (Francesca), Giles S. Holt, de Soyza, Anthony, Perry, Audrey, Lauren eCowley, Clare Veronica Lanyon   +47 more
core   +1 more source

Upregulation of a CFTR mRNA isoform has therapeutic potential for the treatment of 3′ CFTR PTC variants

Molecular Therapy: Nucleic Acids
Nonsense or premature termination codon (PTC) variants of the CFTR gene are pathogenic and found in ∼10% of North American people with cystic fibrosis.
Normand E. Allaire, Matthew S. Armstrong, Jae Seok Yoon, Mercy C. Walker, Priyanka Bhatt, Jan M. Harrington, Yi Cheng, Eric I. Wong, John E. Mahoney, Hillary C. Valley, Caitlin M. Macadino, Hermann J. Bihler, Andrey Y. Sivachenko, Calvin U. Cotton, John P. Carulli, Martin Mense   +15 more
doaj   +1 more source

Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?

Frontiers in Cellular and Infection Microbiology, 2011
IntroductionOrganisms of the Burkholderia cepacia complex (BCC) are important pathogens in cystic fibrosis (CF). The majority of those who acquire BCC develop chronic infection but it can also result in rapid decline in a significant minority.
Alex eHorsley, Alex eHorsley, Kevin eWebb, Kevin eWebb, Rowland eBright-Thomas, John eGovan, Andrew M Jones, Andrew M Jones   +7 more
doaj   +1 more source

Cystic Fibrosis

Disease-a-Month, 1993
Cystic fibrosis, an autosomal recessive disorder, is the most common genetic disease of Caucasians. One in 25 Caucasians are carriers of the gene. The gene is found far less commonly in other races. There are over 230 different alleles of the gene, located on the 7th chromosome.
Savant A, Bojanowski CM, Upadia J.
europepmc   +3 more sources

Health economic modelling in Cystic Fibrosis: a systematic review [PDF]

, 2019
INTRODUCTION: Cystic Fibrosis (CF) is a heritable chronic condition. Due to the genetic and progressive nature of CF, a number of interventions are available for the condition.
Sach, Tracey, Carr, Siobhan, Turner, David, Archangelidi, Olga, Bhadhuri, Arjun, Whitty, Jennifer A., Bilton, Diana, Whitty, Jennifer A, Mohindru, Bishal   +8 more
core   +1 more source